Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections. - Fukaya-Shiba A; Ogata A; Kuribayashi R; Sakurai A; Suzuki K; Takadama S; Nishimura J; Uchiyama J; Ohge H; Takeuchi T; Tamaki H; Matsumoto T; et al. (Frontiers in pharmacology, 2025)